RECURRENT WHO GRADE III GLIOMA
Clinical trials for RECURRENT WHO GRADE III GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT WHO GRADE III GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT WHO GRADE III GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare brain tumors: adaptive trial tests drug cocktails
Disease control Recruiting nowThis study tests whether combining the drug ONC201 with other new agents can help children and young adults with diffuse midline gliomas (DMGs), including DIPG. The trial uses an adaptive design, meaning new drug combinations can be added as research evolves. About 360 participan…
Matched conditions: RECURRENT WHO GRADE III GLIOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New imaging study seeks to unlock secrets of brain tumor metabolism
Knowledge-focused Recruiting nowThis study is testing a special type of MRI scan to see how well it can track changes in lower grade brain tumors. Researchers will scan about 300 people with these tumors to measure metabolic activity in the brain. The goal is to learn if this imaging method can help doctors bet…
Matched conditions: RECURRENT WHO GRADE III GLIOMA
Phase: PHASE1 • Sponsor: Susan Chang • Aim: Knowledge-focused
Last updated May 08, 2026 12:00 UTC